DAIICHI SANKYO S/ADR by Daiichi Sankyo Co., Ltd. (DSNKY)

About DAIICHI SANKYO S/ADR by Daiichi Sankyo Co., Ltd. (DSNKY)

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

DAIICHI SANKYO S/ADR by Daiichi Sankyo Co., Ltd. News